Hanwha Life Insurance한화생명

Hanwha Life shares have fallen sharply over the past month after a weak Q3 loss outlook and dividend uncertainty, though the stock still trades far above its 52-week low.

Hanwha Life is a large Korean life and non-life insurer with asset management and securities units. Over the trailing twelve months to H1 2026 it reported about ₩1.6T operating income and ₩1.1T net income, with a return on equity of 7.6%, while the stock closed at ₩4,115 after a 29.3% fall over one month. Recent headlines point to an expected Q3 loss and lower broker target prices, and the data shows no dividend yield.

What stands out

• Trailing operating income is about ₩1.6T and net income about ₩1.1T, up from ₩1.1T and ₩641B for full-year 2025.
• Trailing free cash flow is negative at about -₩599B, and borrowings are about ₩27.1T against roughly ₩3.0T of cash, with liabilities at about 867% of equity.
• Shares trade at a trailing P/E of 3.4 and P/B of 0.2, well below peers such as Samsung Life (P/E 19.8), though the data does not explain the discount.
• Headlines from October 20 to 21 report a shares drop of over 7% on a Q3 loss outlook and a halt in key product sales, and iM Securities cut its target price to ₩5,400.
• Foreign ownership rose slightly to 8.4% from 8.1% over 60 days, while foreign investors were net sellers over the last 20 days and retail investors were net buyers.

What to watch

• Q3 results and whether the expected loss materialises, as flagged in recent news coverage.
• The dividend outlook, which the news flagged as uncertain; the company currently shows a 0% dividend yield.
• The rights offering decision from September 30 and related-party and affiliated-company transactions disclosed in October, which the data does not explain in detail.